IRIS Accounts Production v25.3.0.601 11938276 Board of Directors 1.5.24 30.4.25 30.4.25 false true false false true false Ordinary 1.00000 Ordinary A 1.00000 Ordinary B 1.00000 50766 19963 125237 56199 120804 126928 46333 50766 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh119382762024-04-30119382762025-04-30119382762024-05-012025-04-30119382762023-04-30119382762023-05-012024-04-30119382762024-04-3011938276ns15:EnglandWales2024-05-012025-04-3011938276ns14:PoundSterling2024-05-012025-04-3011938276ns10:Director12024-05-012025-04-3011938276ns10:PrivateLimitedCompanyLtd2024-05-012025-04-3011938276ns10:SmallEntities2024-05-012025-04-3011938276ns10:AuditExempt-NoAccountantsReport2024-05-012025-04-3011938276ns10:SmallCompaniesRegimeForDirectorsReport2024-05-012025-04-3011938276ns10:SmallCompaniesRegimeForAccounts2024-05-012025-04-3011938276ns10:FullAccounts2024-05-012025-04-3011938276ns10:OrdinaryShareClass12024-05-012025-04-3011938276ns10:OrdinaryShareClass22024-05-012025-04-3011938276ns10:OrdinaryShareClass32024-05-012025-04-3011938276ns10:Director2422024-04-3011938276ns10:Director2422023-04-3011938276ns10:Director2422024-05-012025-04-3011938276ns10:Director2422023-05-012024-04-3011938276ns10:Director2422025-04-3011938276ns10:Director2422024-04-3011938276ns10:Director22024-05-012025-04-3011938276ns10:RegisteredOffice2024-05-012025-04-3011938276ns5:CurrentFinancialInstruments2025-04-3011938276ns5:CurrentFinancialInstruments2024-04-3011938276ns5:ShareCapital2025-04-3011938276ns5:ShareCapital2024-04-3011938276ns5:FurtherSpecificReserve3ComponentTotalEquity2025-04-3011938276ns5:FurtherSpecificReserve3ComponentTotalEquity2024-04-3011938276ns5:RetainedEarningsAccumulatedLosses2025-04-3011938276ns5:RetainedEarningsAccumulatedLosses2024-04-3011938276ns5:PlantMachinery2024-05-012025-04-3011938276ns5:MotorVehicles2024-05-012025-04-3011938276ns5:ComputerEquipment2024-05-012025-04-3011938276ns5:PlantMachinery2024-04-3011938276ns5:MotorVehicles2024-04-3011938276ns5:ComputerEquipment2024-04-3011938276ns5:PlantMachinery2025-04-3011938276ns5:MotorVehicles2025-04-3011938276ns5:ComputerEquipment2025-04-3011938276ns5:PlantMachinery2024-04-3011938276ns5:MotorVehicles2024-04-3011938276ns5:ComputerEquipment2024-04-3011938276ns5:AdditionsToInvestments2025-04-3011938276ns5:DisposalsRepaymentsInvestments2025-04-3011938276ns5:RevaluationsIncreaseDecreaseInInvestments2025-04-3011938276ns5:CostValuation2025-04-3011938276ns5:WithinOneYearns5:CurrentFinancialInstruments2025-04-3011938276ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3011938276ns5:DeferredTaxation2024-04-3011938276ns5:DeferredTaxation2024-05-012025-04-3011938276ns5:DeferredTaxation2025-04-3011938276ns10:OrdinaryShareClass12025-04-3011938276ns10:OrdinaryShareClass22025-04-3011938276ns10:OrdinaryShareClass32025-04-3011938276ns5:RetainedEarningsAccumulatedLosses2024-04-3011938276ns5:FurtherSpecificReserve3ComponentTotalEquity2024-04-3011938276ns5:RetainedEarningsAccumulatedLosses2024-05-012025-04-30119382761ns10:Director12024-04-30119382761ns10:Director12023-04-30119382761ns10:Director12024-05-012025-04-30119382761ns10:Director12023-05-012024-04-30119382761ns10:Director12025-04-30119382761ns10:Director12024-04-30
REGISTERED NUMBER: 11938276 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2025

FOR

WAWRUCH PATHOLOGY SERVICES LIMITED

WAWRUCH PATHOLOGY SERVICES LIMITED (REGISTERED NUMBER: 11938276)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WAWRUCH PATHOLOGY SERVICES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2025







DIRECTORS: Dr P Wawruch
Mrs J Wawruch





REGISTERED OFFICE: 6 Nine Acres
Ipswich
Suffolk
IP2 0DL





REGISTERED NUMBER: 11938276 (England and Wales)





ACCOUNTANTS: LFM
Chartered Certified Accountants
The Stables
23b Lenten Street
Alton
Hampshire
GU34 1HG

WAWRUCH PATHOLOGY SERVICES LIMITED (REGISTERED NUMBER: 11938276)

BALANCE SHEET
30 APRIL 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 13,528 16,129
Investments 5 35,201 -
48,729 16,129

CURRENT ASSETS
Debtors 6 91,818 42,802
Cash at bank 97 52
91,915 42,854
CREDITORS
Amounts falling due within one year 7 76,921 55,307
NET CURRENT ASSETS/(LIABILITIES) 14,994 (12,453 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

63,723

3,676

PROVISIONS FOR LIABILITIES 8 3,325 3,065
NET ASSETS 60,398 611

CAPITAL AND RESERVES
Called up share capital 9 102 102
Fair value reserve 10 173 -
Retained earnings 10 60,123 509
SHAREHOLDERS' FUNDS 60,398 611

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WAWRUCH PATHOLOGY SERVICES LIMITED (REGISTERED NUMBER: 11938276)

BALANCE SHEET - continued
30 APRIL 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 14 October 2025 and were signed on its behalf by:





Dr P Wawruch - Director


WAWRUCH PATHOLOGY SERVICES LIMITED (REGISTERED NUMBER: 11938276)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

1. STATUTORY INFORMATION

Wawruch Pathology Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% straight line
Motor vehicles - 20% on reducing balance
Computer equipment - 20% straight line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

WAWRUCH PATHOLOGY SERVICES LIMITED (REGISTERED NUMBER: 11938276)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 May 2024 622 35,590 4,433 40,645
Additions - - 1,127 1,127
At 30 April 2025 622 35,590 5,560 41,772
DEPRECIATION
At 1 May 2024 596 21,012 2,908 24,516
Charge for year 26 2,916 786 3,728
At 30 April 2025 622 23,928 3,694 28,244
NET BOOK VALUE
At 30 April 2025 - 11,662 1,866 13,528
At 30 April 2024 26 14,578 1,525 16,129

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
Additions 54,968
Disposals (19,998 )
Revaluations 231
At 30 April 2025 35,201
NET BOOK VALUE
At 30 April 2025 35,201

Cost or valuation at 30 April 2025 is represented by:

Other
investments
£   
Valuation in 2025 231
Cost 34,970
35,201

WAWRUCH PATHOLOGY SERVICES LIMITED (REGISTERED NUMBER: 11938276)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 58,535 42,654
Other debtors 32,880 -
Prepayments and accrued income 403 148
91,818 42,802

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Corporation Tax 28,759 2,710
Directors' loan accounts 46,332 50,766
Accrued expenses 1,830 1,831
76,921 55,307

8. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax 3,325 3,065

Deferred
tax
£   
Balance at 1 May 2024 3,065
Provided during year 260
Balance at 30 April 2025 3,325

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary £1 100 100
1 Ordinary A £1 1 1
1 Ordinary B £1 1 1
102 102

WAWRUCH PATHOLOGY SERVICES LIMITED (REGISTERED NUMBER: 11938276)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2025

10. RESERVES
Fair
Retained value
earnings reserve Totals
£    £    £   

At 1 May 2024 509 - 509
Profit for the year 91,287 91,287
Dividends (31,500 ) (31,500 )
Value to fair value reserve (173 ) 173 -
At 30 April 2025 60,123 173 60,296

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 April 2025 and 30 April 2024:

2025 2024
£    £   
Dr P Wawruch and Mrs J Wawruch
Balance outstanding at start of year (50,766 ) 19,963
Amounts advanced 125,237 56,199
Amounts repaid (120,804 ) (126,928 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (46,333 ) (50,766 )

Interest on the overdrawn directors loan has been charged at 2.25% per annum.

12. ULTIMATE CONTROLLING PARTY

The controlling party is Dr P Wawruch.